ArticleJCI insight2022

Cure of syngeneic carcinomas with targeted IL-12 through obligate reprogramming of lymphoid and myeloid immunity.

Youji Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.